SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-052706
Filing Date
2024-06-14
Accepted
2024-06-14 11:33:12
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207909-8k_immucell.htm   iXBRL 8-K 34810
  Complete submission text file 0001213900-24-052706.txt   206853

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE iccc-20240613.xsd EX-101.SCH 3015
3 XBRL LABEL FILE iccc-20240613_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE iccc-20240613_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0207909-8k_immucell_htm.xml XML 3558
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 241043619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)